Stay updated with breaking news from Efficacy Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Echoing the views of Opposition-ruled states that have questioned the emergency use authorisation given to Bharat Biotechs Covaxin without phase-III trials being completed, Banerjee pointed out that doubts had been expressed about the vaccines as the efficacy data had not been put out in public domain.
MUMBAI: The debate among medical professionals now is which one of the two vaccines granted emergency-use approval would they take, if given a choice. Several doctors, including KEM Hospital dean Dr Hemant Deshmukh, said Covishield, developed by Oxford-AstraZeneca and manufactured by Serum Institute of India, would be their preferred vaccine since Covaxin’s efficacy data is not available yet. Incidentally, KEM was one of the sites where Covishield’s trial was conducted. “The reason is simple. We have to see Covaxin’s efficacy data and that trial is still on,” he explained. Interes...
An affiliate of China's state-owned drug maker Sinopharm said on Wednesday its COVID-19 vaccine showed 79.34% efficacy and it has requested regulatory approval of the shot, moving a step closer to become China's first approved vaccine for general public use. The efficacy rate, based on an interim analysis of Phase III clinical trials, is lower than 86% rate for the same vaccine announced by the United Arab Emirates on Dec. 9, based on preliminary data from trials there. There have been fragmentary releases of efficacy data for Chinese vaccine makers' COVID-19 candidates, which...